Pei-Yu Chen, BS, MS, PhD, Senior Research Scientist, Cardiovascular Medicine, at Yale University, has been awarded a two-year grant through the Vasculitis Foundation’s Young Investigator’s Award Program for her study, “siRNA Nanoparticle Targeting Endothelial Cell TGFβ Signaling Against ANCA-Vasculitis.” The aim is to reveal how large a role TGFβ-mediated EndMT…...
David Massicotte-Azarniouch, MD, Awarded Two-Year Grant Through VF’s Young Investigator’s Award Program
David Massicotte-Azarniouch, MD, Assistant Professor at the University of Ottawa and Associate Scientist at the Ottawa Hospital Research Institute in Ontario, Canada, has been awarded a two-year grant through the Vasculitis Foundation’s Young Investigator’s Award Program. The aim of his study, “Steroid Minimization in ANCA-Associated Vasculitis For Safe Effective Treatment…...
Introducing Our 2022-2023 VCRC-VF Fellow: Marta Casal Moura, MD, MSc, MSPH
Marta Casal Moura, MD, MSc, MSPH, began her one-year Vasculitis Clinical Research Consortium (VCRC)-Vasculitis Foundation (VF) Fellowship in July 2022. For anti-neutrophil autoantibody (ANCA)-associated vasculitis (AAV), she is studying the predictors of response to plasma exchange in patients who have AAV glomerulonephritis and how histologic scores can predict the response…...
Amgen Successfully Completes Acquisition of ChemoCentryx
TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif., (Oct. 20, 2022) – Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced acquisition of ChemoCentryx, Inc. (NASDAQ: CCXI), a biopharmaceutical company focused on orally administered therapeutics to treat…...
Many Outstanding Questions Still Exist for Vasculitis Patients: The Massachusetts General Hospital Rheumatology Vasculitis Program Hopes to Find Some of the Answers
Zachary Wallace, MD, MSc (left) and Sebastian Unizony, MD Vasculitis tends to present in a systemic manner, often affecting multiple organ systems. Clinicians should consider a broad differential (possible conditions that share the same symptoms) and think about the entire person—not just at the time of diagnosis but throughout their…...
